Low doses of dexamethasone suppress pituitary-adrenal function but augment the glycemic response to acute hypoxemia in fetal sheep during late gestation.
Despite the widespread use of antenatal glucocorticoid therapy in obstetric practice, little is known about the effects of synthetic glucocorticoids on the fetal capacity to respond to episodes of acute hypoxemia, such as may occur during labor and delivery. This study investigated the effects of prolonged fetal exposure to low concentrations of dexamethasone on the fetal ACTH, cortisol, and glycemic responses to an episode of acute hypoxemia during the period of dexamethasone treatment in sheep. At 118 d of gestation (term is approximately 145 d), 11 fetal sheep had catheters implanted under halothane anesthesia. From 124 d, five fetuses were infused i.v. continuously with dexamethasone (1.80 +/- 0.15 microg x kg(-1) x h(-1) in 0.9% saline at 0.5 mL/h) for 48 h, and the other six fetuses received saline solution i.v. at the same rate. At 45 h of infusion, acute hypoxemia was induced in all fetuses for 1 h by reducing the maternal inspired fraction of oxygen. During glucocorticoid treatment, fetal plasma dexamethasone concentrations increased to 3.9 +/- 0.2 nM by 24 h and remained elevated for the rest of the infusion period. During hypoxemia, a similar fall in fetal arterial PO2 occurred in both saline-infused and dexamethasone-treated fetuses. In control fetuses, significant increases in plasma ACTH and cortisol concentrations and in blood glucose concentrations occurred during hypoxemia. Dexamethasone treatment prevented the increases in fetal plasma ACTH and cortisol, and augmented the blood glucose response, induced by hypoxemia. These data indicate that prolonged fetal exposure to low concentrations of dexamethasone suppresses pituitary-adrenal function, but augments the glycemic response, to acute hypoxemia in fetal sheep during late gestation.
Fletcher
A J
AJ
Department of Physiology, University of Cambridge, United Kingdom.
Goodfellow
M R
MR
Forhead
A J
AJ
Gardner
D S
DS
McGarrigle
H H
HH
Fowden
A L
AL
Giussani
D A
DA
D000136:Acid-Base Equilibrium / Q000187:drug effects; D000324:Adrenocorticotropic Hormone / Q000097:blood; D000818:Animals; D001013:Aorta, Thoracic / Q000502:physiology; D001784:Blood Gas Analysis; D001786:Blood Glucose / Q000187:drug effects*; D002339:Carotid Arteries / Q000502:physiology; D002408:Catheters, Indwelling; D003907:Dexamethasone / Q000008:administration & dosage* / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005260:Female; D005333:Fetus / Q000187:drug effects* / Q000378:metabolism / Q000601:surgery; D005865:Gestational Age; D006454:Hemoglobins / Q000032:analysis; D006854:Hydrocortisone / Q000097:blood; D000860:Hypoxia / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D007262:Infusions, Intravenous; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011247:Pregnancy; D012756:Sheep
D001786:Blood Glucose; D006454:Hemoglobins; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone